Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innovation Expands Artificial Lung Market

Executive Summary

Advances in extracorporeal lung support devices are expanding the market for artificial lungs and are helping to extend and save the lives of patients with acute and chronic pulmonary disease. At the Society of Thoracic Surgeons' annual meeting held in San Diego in January, researchers discussed new low-flow percutaneous catheters, advances in low-resistance membrane oxygenators, and improvements in pump designs that are enabling simpler, less invasive, and more portable solutions for treating patients with respiratory failure.

You may also be interested in...



Obesity 2016: Minimally Invasive Bariatric Devices Gaining Steam

With no end in sight for the obesity epidemic, there is a vast and underserved market opportunity for manufacturers developing minimally invasive solutions for obesity that can fill the treatment gap between invasive bariatric surgery and conservative weight loss methods (diet, exercise, and drugs). Despite some high-profile setbacks in the last few years, the market for minimally invasive bariatric devices is gaining steam as several companies have recently launched obesity devices on the US market while others have completed clinical trials and are advancing toward US regulatory approval.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035422

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel